This site contains promotional content intended for Healthcare Professionals in Ireland and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Explore the resources outlined below to gain further insights into EYLEA® 8mg (114.3 mg/ml aflibercept) in neovascular (wet) age-related macular degeneration (nAMD) and diabetic macular oedema (DME).

PFS Image

Key steps for preparing and injecting OcuClick®

Below you will find the key steps that must be followed when preparing for intravitreal injection using OcuClick.

Always consult the OcuClick instructions for use (IFU) card
, which provides more detail for each step.

Dosing Guide - Eylea

Flexible Dosing Options

Dosing regimens in nAMD and DME

Insurance Code Thumbnail

Eylea® 8mg - Insurance Claim Codes

Contains codes for major Irish insurance organisations

PP-EYL_8mg-IE-0162-1   |   December 2025